CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: thifluzamide
Accession: CHEBI:81794
browse the term
Definition: An aromatic amide obtained by formal condensation of the carboxy group of 2-methyl-4-(trifluoromethyl)thiazole-5-carboxylic acid with the amino group of 2,6-dibromo-4-(trifluoromethoxy)aniline. Used to control Rhizoctonia spp. diseases on rice, potatoes, maize, grass and other crops.
Synonyms: exact_synonym: N-[2,6-dibromo-4-(trifluoromethoxy)phenyl]-2-methyl-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide
related_synonym: 2',6'-dibromo-2-methyl-4'-trifluoromethoxy-4-trifluoromethyl-1,3-thiazole-5-carboxanilide; Formula=C13H6Br2F6N2O2S; InChI=1S/C13H6Br2F6N2O2S/c1-4-22-10(12(16,17)18)9(26-4)11(24)23-8-6(14)2-5(3-7(8)15)25-13(19,20)21/h2-3H,1H3,(H,23,24); InChIKey=WOSNCVAPUOFXEH-UHFFFAOYSA-N; N-[2,6-dibromo-4-(trifluoromethoxy)phenyl]-2-methyl-4-(trifluoromethyl)-5-thiazolecarboxamide; SMILES=Cc1nc(c(s1)C(=O)Nc1c(Br)cc(OC(F)(F)F)cc1Br)C(F)(F)F
xref: CAS:130000-40-7; KEGG:C18505
xref_mesh: MESH:C494892
xref: PMID:15350409; PPDB:1209; Patent:CN101637164; Patent:CN101828559; Patent:CN101828560; Patent:CN101828564; Patent:CN101861866; Patent:EP0791585; Patent:NZ576314; Patent:US6043262; Patent:WO9731908; Pesticides:thifluzamide; Reaxys:11004210
G
AARS1
alanyl-tRNA synthetase 1
increases expression
EXP
thifluzamide results in increased expression of AARS1 mRNA
CTD
PMID:33512557
NCBI chr16:70,252,298...70,289,506
Ensembl chr16:70,251,983...70,289,707
G
AKT1
AKT serine/threonine kinase 1
decreases expression
EXP
thifluzamide results in decreased expression of AKT1 mRNA
CTD
PMID:33512557
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
G
ALDH7A1
aldehyde dehydrogenase 7 family member A1
decreases expression
EXP
thifluzamide results in decreased expression of ALDH7A1 mRNA
CTD
PMID:33512557
NCBI chr 5:126,541,841...126,595,219
Ensembl chr 5:126,531,200...126,595,362
G
ALDOA
aldolase, fructose-bisphosphate A
increases expression
EXP
thifluzamide results in increased expression of ALDOA mRNA
CTD
PMID:33512557
NCBI chr16:30,064,279...30,070,420
Ensembl chr16:30,064,164...30,070,457
G
ANXA2
annexin A2
decreases expression
EXP
thifluzamide results in decreased expression of ANXA2 mRNA
CTD
PMID:33512557
NCBI chr15:60,347,151...60,397,986
Ensembl chr15:60,347,134...60,402,883
G
ARHGAP8
Rho GTPase activating protein 8
increases expression
EXP
thifluzamide results in increased expression of ARHGAP8 mRNA
CTD
PMID:33512557
NCBI chr22:44,752,575...44,862,784
Ensembl chr22:44,752,558...44,862,788
G
ARHGAP9
Rho GTPase activating protein 9
increases expression
EXP
thifluzamide results in increased expression of ARHGAP9 mRNA
CTD
PMID:33512557
NCBI chr12:57,472,269...57,488,824
Ensembl chr12:57,472,264...57,488,814
G
ARHGEF2
Rho/Rac guanine nucleotide exchange factor 2
increases expression
EXP
thifluzamide results in increased expression of ARHGEF2 mRNA
CTD
PMID:33512557
NCBI chr 1:155,946,854...155,979,617
Ensembl chr 1:155,946,851...156,007,070
G
ARID4A
AT-rich interaction domain 4A
decreases expression
EXP
thifluzamide results in decreased expression of ARID4A mRNA
CTD
PMID:33512557
NCBI chr14:58,298,555...58,373,876
Ensembl chr14:58,298,504...58,373,887
G
ARRDC4
arrestin domain containing 4
decreases expression
EXP
thifluzamide results in decreased expression of ARRDC4 mRNA
CTD
PMID:33512557
NCBI chr15:97,960,703...97,973,833
Ensembl chr15:97,960,703...97,973,833
G
ARSG
arylsulfatase G
increases expression
EXP
thifluzamide results in increased expression of ARSG mRNA
CTD
PMID:33512557
NCBI chr17:68,259,170...68,452,019
Ensembl chr17:68,259,182...68,422,731
G
ASNS
asparagine synthetase (glutamine-hydrolyzing)
increases expression
EXP
thifluzamide results in increased expression of ASNS mRNA
CTD
PMID:33512557
NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542
G
ASS1
argininosuccinate synthase 1
increases expression
EXP
thifluzamide results in increased expression of ASS1 mRNA
CTD
PMID:33512557
NCBI chr 9:130,444,707...130,501,274
Ensembl chr 9:130,444,961...130,501,274
G
ATF4
activating transcription factor 4
increases expression
EXP
thifluzamide results in increased expression of ATF4 mRNA
CTD
PMID:33512557
NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,683
G
ATF5
activating transcription factor 5
increases expression
EXP
thifluzamide results in increased expression of ATF5 mRNA
CTD
PMID:33512557
NCBI chr19:49,928,906...49,933,935
Ensembl chr19:49,928,702...49,933,935
G
AURKB
aurora kinase B
increases expression
EXP
thifluzamide results in increased expression of AURKB mRNA
CTD
PMID:33512557
NCBI chr17:8,204,731...8,210,575
Ensembl chr17:8,204,733...8,210,600
G
BID
BH3 interacting domain death agonist
decreases expression
EXP
thifluzamide results in decreased expression of BID mRNA
CTD
PMID:33512557
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
G
BIRC2
baculoviral IAP repeat containing 2
decreases expression
EXP
thifluzamide results in decreased expression of BIRC2 mRNA
CTD
PMID:33512557
NCBI chr11:102,347,214...102,378,670
Ensembl chr11:102,347,211...102,378,670
G
BIRC5
baculoviral IAP repeat containing 5
increases expression
EXP
thifluzamide results in increased expression of BIRC5 mRNA
CTD
PMID:33512557
NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
G
BMF
Bcl2 modifying factor
decreases expression
EXP
thifluzamide results in decreased expression of BMF mRNA
CTD
PMID:33512557
NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,890...40,108,892
G
BPHL
biphenyl hydrolase like
decreases expression
EXP
thifluzamide results in decreased expression of BPHL mRNA
CTD
PMID:33512557
NCBI chr 6:3,118,376...3,153,578
Ensembl chr 6:3,118,374...3,153,578
G
BSG
basigin (Ok blood group)
increases expression
EXP
thifluzamide results in increased expression of BSG mRNA
CTD
PMID:33512557
NCBI chr19:571,283...583,493
Ensembl chr19:571,277...583,494
G
C1D
C1D nuclear receptor corepressor
increases expression
EXP
thifluzamide results in increased expression of C1D mRNA
CTD
PMID:33512557
NCBI chr 2:68,041,130...68,063,004
Ensembl chr 2:68,041,130...68,110,948
G
C2CD5
C2 calcium dependent domain containing 5
decreases expression
EXP
thifluzamide results in decreased expression of C2CD5 mRNA
CTD
PMID:33512557
NCBI chr12:22,448,583...22,544,542
Ensembl chr12:22,448,583...22,544,546
G
CAMK2B
calcium/calmodulin dependent protein kinase II beta
decreases expression
EXP
thifluzamide results in decreased expression of CAMK2B mRNA
CTD
PMID:33512557
NCBI chr 7:44,217,154...44,326,013
Ensembl chr 7:44,210,019...44,334,577
G
CARS1
cysteinyl-tRNA synthetase 1
increases expression
EXP
thifluzamide results in increased expression of CARS1 mRNA
CTD
PMID:33512557
NCBI chr11:3,000,929...3,057,423
Ensembl chr11:3,000,922...3,057,613
G
CBX4
chromobox 4
increases expression
EXP
thifluzamide results in increased expression of CBX4 mRNA
CTD
PMID:33512557
NCBI chr17:79,833,156...79,839,440
Ensembl chr17:79,833,156...79,839,440
G
CCNB2
cyclin B2
increases expression
EXP
thifluzamide results in increased expression of CCNB2 mRNA
CTD
PMID:33512557
NCBI chr15:59,105,146...59,125,045
Ensembl chr15:59,105,126...59,125,045
G
CCNE2
cyclin E2
decreases expression
EXP
thifluzamide results in decreased expression of CCNE2 mRNA
CTD
PMID:33512557
NCBI chr 8:94,880,224...94,896,693
Ensembl chr 8:94,879,770...94,896,678
G
CD24
CD24 molecule
decreases expression
EXP
thifluzamide results in decreased expression of CD24 mRNA
CTD
PMID:33512557
NCBI chr 6:106,969,831...106,976,855
Ensembl chr 6:106,969,831...106,975,627
G
CDH10
cadherin 10
decreases expression
EXP
thifluzamide results in decreased expression of CDH10 mRNA
CTD
PMID:33512557
NCBI chr 5:24,487,100...24,644,978
Ensembl chr 5:24,487,100...24,644,978
G
CDK1
cyclin dependent kinase 1
increases expression
EXP
thifluzamide results in increased expression of CDK1 mRNA
CTD
PMID:33512557
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
G
CDK5
cyclin dependent kinase 5
decreases expression
EXP
thifluzamide results in decreased expression of CDK5 mRNA
CTD
PMID:33512557
NCBI chr 7:151,053,815...151,057,897
Ensembl chr 7:151,053,815...151,057,897
G
CDKN3
cyclin dependent kinase inhibitor 3
increases expression
EXP
thifluzamide results in increased expression of CDKN3 mRNA
CTD
PMID:33512557
NCBI chr14:54,397,007...54,420,218
Ensembl chr14:54,396,849...54,420,218
G
CEBPB
CCAAT enhancer binding protein beta
increases expression
EXP
thifluzamide results in increased expression of CEBPB mRNA
CTD
PMID:33512557
NCBI chr20:50,190,583...50,192,690
Ensembl chr20:50,190,830...50,192,668
G
CEP55
centrosomal protein 55
increases expression
EXP
thifluzamide results in increased expression of CEP55 mRNA
CTD
PMID:33512557
NCBI chr10:93,496,612...93,529,092
Ensembl chr10:93,496,612...93,529,092
G
CHAC1
ChaC glutathione specific gamma-glutamylcyclotransferase 1
increases expression
EXP
thifluzamide results in increased expression of CHAC1 mRNA
CTD
PMID:33512557
NCBI chr15:40,953,471...40,956,512
Ensembl chr15:40,952,962...40,956,512
G
CHKA
choline kinase alpha
increases expression
EXP
thifluzamide results in increased expression of CHKA mRNA
CTD
PMID:33512557
NCBI chr11:68,052,859...68,121,388
Ensembl chr11:68,052,859...68,121,444
G
CHRNA4
cholinergic receptor nicotinic alpha 4 subunit
decreases expression
EXP
thifluzamide results in decreased expression of CHRNA4 mRNA
CTD
PMID:33512557
NCBI chr20:63,343,223...63,361,349
Ensembl chr20:63,343,223...63,378,401
G
CKS2
CDC28 protein kinase regulatory subunit 2
increases expression
EXP
thifluzamide results in increased expression of CKS2 mRNA
CTD
PMID:33512557
NCBI chr 9:89,311,195...89,316,703
Ensembl chr 9:89,311,195...89,316,703
G
CLDN5
claudin 5
decreases expression
EXP
thifluzamide results in decreased expression of CLDN5 mRNA
CTD
PMID:33512557
NCBI chr22:19,523,024...19,525,337
Ensembl chr22:19,523,024...19,527,545
G
CLIC4
chloride intracellular channel 4
increases expression
EXP
thifluzamide results in increased expression of CLIC4 mRNA
CTD
PMID:33512557
NCBI chr 1:24,745,447...24,844,321
Ensembl chr 1:24,745,382...24,844,321
G
CPNE3
copine 3
decreases expression
EXP
thifluzamide results in decreased expression of CPNE3 mRNA
CTD
PMID:33512557
NCBI chr 8:86,514,435...86,561,498
Ensembl chr 8:86,514,435...86,561,498
G
CPSF4
cleavage and polyadenylation specific factor 4
decreases expression
EXP
thifluzamide results in decreased expression of CPSF4 mRNA
CTD
PMID:33512557
NCBI chr 7:99,438,943...99,457,373
Ensembl chr 7:99,438,922...99,457,373
G
CREG1
cellular repressor of E1A stimulated genes 1
increases expression
EXP
thifluzamide results in increased expression of CREG1 mRNA
CTD
PMID:33512557
NCBI chr 1:167,541,013...167,553,762
Ensembl chr 1:167,529,117...167,553,805
G
CRTAP
cartilage associated protein
increases expression
EXP
thifluzamide results in increased expression of CRTAP mRNA
CTD
PMID:33512557
NCBI chr 3:33,114,014...33,147,773
Ensembl chr 3:33,114,014...33,147,773
G
CTH
cystathionine gamma-lyase
increases expression
EXP
thifluzamide results in increased expression of CTH mRNA
CTD
PMID:33512557
NCBI chr 1:70,411,268...70,439,851
Ensembl chr 1:70,411,218...70,439,851
G
CTNND1
catenin delta 1
decreases expression
EXP
thifluzamide results in decreased expression of CTNND1 mRNA
CTD
PMID:33512557
NCBI chr11:57,761,802...57,819,540
Ensembl chr11:57,753,243...57,819,546
G
CTSS
cathepsin S
decreases expression
EXP
thifluzamide results in decreased expression of CTSS mRNA
CTD
PMID:33512557
NCBI chr 1:150,730,188...150,765,778
Ensembl chr 1:150,730,079...150,765,957
G
CXCR4
C-X-C motif chemokine receptor 4
decreases expression
EXP
thifluzamide results in decreased expression of CXCR4 mRNA
CTD
PMID:33512557
NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
G
DAAM1
dishevelled associated activator of morphogenesis 1
decreases expression
EXP
thifluzamide results in decreased expression of DAAM1 mRNA
CTD
PMID:33512557
NCBI chr14:59,188,667...59,371,405
Ensembl chr14:59,188,646...59,371,405
G
DCX
doublecortin
decreases expression
EXP
thifluzamide results in decreased expression of DCX mRNA
CTD
PMID:33512557
NCBI chr X:111,293,779...111,412,192
Ensembl chr X:111,293,779...111,412,429
G
DDC
dopa decarboxylase
decreases expression
EXP
thifluzamide results in decreased expression of DDC mRNA
CTD
PMID:33512557
NCBI chr 7:50,458,442...50,565,405
Ensembl chr 7:50,458,436...50,565,405
G
DDIT3
DNA damage inducible transcript 3
increases expression
EXP
thifluzamide results in increased expression of DDIT3 mRNA
CTD
PMID:33512557
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
G
DDIT4
DNA damage inducible transcript 4
increases expression
EXP
thifluzamide results in increased expression of DDIT4 mRNA
CTD
PMID:33512557
NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
G
DEPDC1B
DEP domain containing 1B
increases expression
EXP
thifluzamide results in increased expression of DEPDC1B mRNA
CTD
PMID:33512557
NCBI chr 5:60,596,912...60,700,166
Ensembl chr 5:60,596,912...60,700,190
G
DNM1
dynamin 1
decreases expression
EXP
thifluzamide results in decreased expression of DNM1 mRNA
CTD
PMID:33512557
NCBI chr 9:128,203,379...128,255,244
Ensembl chr 9:128,191,655...128,255,248
G
DPM2
dolichyl-phosphate mannosyltransferase subunit 2, regulatory
increases expression
EXP
thifluzamide results in increased expression of DPM2 mRNA
CTD
PMID:33512557
NCBI chr 9:127,935,099...127,937,854
Ensembl chr 9:127,935,099...127,937,854
G
DRD2
dopamine receptor D2
decreases expression
EXP
thifluzamide results in decreased expression of DRD2 mRNA
CTD
PMID:33512557
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
DUSP14
dual specificity phosphatase 14
increases expression
EXP
thifluzamide results in increased expression of DUSP14 mRNA
CTD
PMID:33512557
NCBI chr17:37,488,566...37,513,498
Ensembl chr17:37,489,891...37,513,501
G
DUSP22
dual specificity phosphatase 22
increases expression
EXP
thifluzamide results in increased expression of DUSP22 mRNA
CTD
PMID:33512557
NCBI chr 6:292,487...351,355
Ensembl chr 6:291,630...351,355
G
DUSP4
dual specificity phosphatase 4
increases expression
EXP
thifluzamide results in increased expression of DUSP4 mRNA
CTD
PMID:33512557
NCBI chr 8:29,333,064...29,350,684
Ensembl chr 8:29,333,064...29,350,684
G
EEA1
early endosome antigen 1
increases expression
EXP
thifluzamide results in increased expression of EEA1 mRNA
CTD
PMID:33512557
NCBI chr12:92,770,637...92,929,295
Ensembl chr12:92,770,637...92,929,331
G
EGR1
early growth response 1
increases expression
EXP
thifluzamide results in increased expression of EGR1 mRNA
CTD
PMID:33512557
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
EIF1
eukaryotic translation initiation factor 1
increases expression
EXP
thifluzamide results in increased expression of EIF1 mRNA
CTD
PMID:33512557
NCBI chr17:41,688,885...41,692,668
Ensembl chr17:41,688,885...41,692,668
G
EIF2S2
eukaryotic translation initiation factor 2 subunit beta
increases expression
EXP
thifluzamide results in increased expression of EIF2S2 mRNA
CTD
PMID:33512557
NCBI chr20:34,088,309...34,112,243
Ensembl chr20:34,088,309...34,112,243
G
EIF4EBP1
eukaryotic translation initiation factor 4E binding protein 1
increases expression
EXP
thifluzamide results in increased expression of EIF4EBP1 mRNA
CTD
PMID:33512557
NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
G
ELMOD1
ELMO domain containing 1
decreases expression
EXP
thifluzamide results in decreased expression of ELMOD1 mRNA
CTD
PMID:33512557
NCBI chr11:107,591,147...107,666,779
Ensembl chr11:107,591,091...107,666,779
G
EPHB2
EPH receptor B2
decreases expression
EXP
thifluzamide results in decreased expression of EPHB2 mRNA
CTD
PMID:33512557
NCBI chr 1:22,710,838...22,921,500
Ensembl chr 1:22,710,839...22,921,500
G
EPS15
epidermal growth factor receptor pathway substrate 15
increases expression
EXP
thifluzamide results in increased expression of EPS15 mRNA
CTD
PMID:33512557
NCBI chr 1:51,354,263...51,519,266
Ensembl chr 1:51,354,263...51,519,328
G
ERO1A
endoplasmic reticulum oxidoreductase 1 alpha
increases expression
EXP
thifluzamide results in increased expression of ERO1A mRNA
CTD
PMID:33512557
NCBI chr14:52,639,915...52,695,558
Ensembl chr14:52,639,915...52,695,900
G
ETNK1
ethanolamine kinase 1
decreases expression
EXP
thifluzamide results in decreased expression of ETNK1 mRNA
CTD
PMID:33512557
NCBI chr12:22,625,171...22,690,665
Ensembl chr12:22,625,075...22,690,665
G
ETS1
ETS proto-oncogene 1, transcription factor
increases expression
EXP
thifluzamide results in increased expression of ETS1 mRNA
CTD
PMID:33512557
NCBI chr11:128,458,765...128,587,558
Ensembl chr11:128,458,761...128,587,558
G
ETV1
ETS variant transcription factor 1
decreases expression
EXP
thifluzamide results in decreased expression of ETV1 mRNA
CTD
PMID:33512557
NCBI chr 7:13,891,229...13,991,425
Ensembl chr 7:13,891,229...13,991,425
G
EXOSC4
exosome component 4
decreases expression
EXP
thifluzamide results in decreased expression of EXOSC4 mRNA
CTD
PMID:33512557
NCBI chr 8:144,064,056...144,080,648
Ensembl chr 8:144,078,648...144,080,648
G
EXOSC8
exosome component 8
increases expression
EXP
thifluzamide results in increased expression of EXOSC8 mRNA
CTD
PMID:33512557
NCBI chr13:37,000,786...37,009,614
Ensembl chr13:36,998,816...37,025,881
G
FAM72A
family with sequence similarity 72 member A
increases expression
EXP
thifluzamide results in increased expression of FAM72A mRNA
CTD
PMID:33512557
NCBI chr 1:206,186,179...206,205,773
Ensembl chr 1:206,186,179...206,204,414
G
FGF8
fibroblast growth factor 8
decreases expression
EXP
thifluzamide results in decreased expression of FGF8 mRNA
CTD
PMID:33512557
NCBI chr10:101,770,109...101,780,369
Ensembl chr10:101,770,109...101,780,371
G
FIBIN
fin bud initiation factor homolog
increases expression
EXP
thifluzamide results in increased expression of FIBIN mRNA
CTD
PMID:33512557
NCBI chr11:26,994,112...26,997,087
Ensembl chr11:26,994,112...26,997,087
G
FLNA
filamin A
increases expression
EXP
thifluzamide results in increased expression of FLNA mRNA
CTD
PMID:33512557
NCBI chr X:154,348,531...154,374,634
Ensembl chr X:154,348,524...154,374,634
G
FTH1
ferritin heavy chain 1
increases expression
EXP
thifluzamide results in increased expression of FTH1 mRNA
CTD
PMID:33512557
NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634
G
FTL
ferritin light chain
increases expression
EXP
thifluzamide results in increased expression of FTL mRNA
CTD
PMID:33512557
NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,966,879
G
GADD45A
growth arrest and DNA damage inducible alpha
increases expression
EXP
thifluzamide results in increased expression of GADD45A mRNA
CTD
PMID:33512557
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
G
GADD45B
growth arrest and DNA damage inducible beta
increases expression
EXP
thifluzamide results in increased expression of GADD45B mRNA
CTD
PMID:33512557
NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,259
G
GALNT3
polypeptide N-acetylgalactosaminyltransferase 3
decreases expression
EXP
thifluzamide results in decreased expression of GALNT3 mRNA
CTD
PMID:33512557
NCBI chr 2:165,747,588...165,794,692
Ensembl chr 2:165,747,588...165,794,659
G
GCLM
glutamate-cysteine ligase modifier subunit
increases expression
EXP
thifluzamide results in increased expression of GCLM mRNA
CTD
PMID:33512557
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
GDF15
growth differentiation factor 15
increases expression
EXP
thifluzamide results in increased expression of GDF15 mRNA
CTD
PMID:33512557
NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176
G
GLDC
glycine decarboxylase
decreases expression
EXP
thifluzamide results in decreased expression of GLDC mRNA
CTD
PMID:33512557
NCBI chr 9:6,532,467...6,645,729
Ensembl chr 9:6,532,467...6,645,729
G
GLRX
glutaredoxin
decreases expression
EXP
thifluzamide results in decreased expression of GLRX mRNA
CTD
PMID:33512557
NCBI chr 5:95,813,849...95,822,726
Ensembl chr 5:95,751,319...95,822,726
G
GMIP
GEM interacting protein
decreases expression
EXP
thifluzamide results in decreased expression of GMIP mRNA
CTD
PMID:33512557
NCBI chr19:19,629,476...19,643,657
Ensembl chr19:19,629,476...19,643,657
G
GNAI2
G protein subunit alpha i2
decreases expression
EXP
thifluzamide results in decreased expression of GNAI2 mRNA
CTD
PMID:33512557
NCBI chr 3:50,227,068...50,263,358
Ensembl chr 3:50,226,292...50,259,362
G
GNB3
G protein subunit beta 3
decreases expression
EXP
thifluzamide results in decreased expression of GNB3 mRNA
CTD
PMID:33512557
NCBI chr12:6,840,925...6,847,393
Ensembl chr12:6,839,954...6,847,393
G
GOT1
glutamic-oxaloacetic transaminase 1
increases expression
EXP
thifluzamide results in increased expression of GOT1 mRNA
CTD
PMID:33512557
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
G
GRB10
growth factor receptor bound protein 10
increases expression
EXP
thifluzamide results in increased expression of GRB10 mRNA
CTD
PMID:33512557
NCBI chr 7:50,590,068...50,793,453
Ensembl chr 7:50,590,063...50,793,462
G
GRIA2
glutamate ionotropic receptor AMPA type subunit 2
decreases expression
EXP
thifluzamide results in decreased expression of GRIA2 mRNA
CTD
PMID:33512557
NCBI chr 4:157,220,120...157,366,075
Ensembl chr 4:157,204,182...157,387,146
G
GRIN2D
glutamate ionotropic receptor NMDA type subunit 2D
decreases expression
EXP
thifluzamide results in decreased expression of GRIN2D mRNA
CTD
PMID:33512557
NCBI chr19:48,393,668...48,444,931
Ensembl chr19:48,393,668...48,444,931
G
GRM4
glutamate metabotropic receptor 4
decreases expression
EXP
thifluzamide results in decreased expression of GRM4 mRNA
CTD
PMID:33512557
NCBI chr 6:34,018,643...34,155,622
Ensembl chr 6:34,018,643...34,155,622
G
GSR
glutathione-disulfide reductase
increases expression
EXP
thifluzamide results in increased expression of GSR mRNA
CTD
PMID:33512557
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
GSTM2
glutathione S-transferase mu 2
decreases expression
EXP
thifluzamide results in decreased expression of GSTM2 mRNA
CTD
PMID:33512557
NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
G
H1-0
H1.0 linker histone
increases expression
EXP
thifluzamide results in increased expression of H1-0 mRNA
CTD
PMID:33512557
NCBI chr22:37,805,229...37,807,432
Ensembl chr22:37,805,229...37,807,432
G
H1-2
H1.2 linker histone, cluster member
increases expression
EXP
thifluzamide results in increased expression of H1-2 mRNA
CTD
PMID:33512557
NCBI chr 6:26,055,740...26,056,470
Ensembl chr 6:26,055,740...26,056,470
G
H2AC11
H2A clustered histone 11
increases expression
EXP
thifluzamide results in increased expression of H2AC11 mRNA
CTD
PMID:33512557
NCBI chr 6:27,133,043...27,133,535
Ensembl chr 6:27,133,043...27,133,535
G
H2AC15
H2A clustered histone 15
increases expression
EXP
thifluzamide results in increased expression of H2AC15 mRNA
CTD
PMID:33512557
NCBI chr 6:27,837,880...27,838,375
Ensembl chr 6:27,837,880...27,838,375
G
H2AC19
H2A clustered histone 19
increases expression
EXP
thifluzamide results in increased expression of H2AC19 mRNA
CTD
PMID:33512557
NCBI chr 1:149,851,061...149,851,594
Ensembl chr 1:149,851,061...149,851,594
G
H2AC6
H2A clustered histone 6
increases expression
EXP
thifluzamide results in increased expression of H2AC6 mRNA
CTD
PMID:33512557
NCBI chr 6:26,124,172...26,124,690
Ensembl chr 6:26,124,145...26,139,116
G
H2BC3
H2B clustered histone 3
increases expression
EXP
thifluzamide results in increased expression of H2BC3 mRNA
CTD
PMID:33512557
NCBI chr 6:26,043,227...26,043,713
Ensembl chr 6:26,043,227...26,043,713
G
H2BC5
H2B clustered histone 5
increases expression
EXP
thifluzamide results in increased expression of H2BC5 mRNA
CTD
PMID:33512557
NCBI chr 6:26,158,121...26,171,349
Ensembl chr 6:26,158,122...26,171,349
G
H3C10
H3 clustered histone 10
increases expression
EXP
thifluzamide results in increased expression of H3C10 mRNA
CTD
PMID:33512557
NCBI chr 6:27,810,051...27,810,536
Ensembl chr 6:27,810,051...27,811,300
G
H3C2
H3 clustered histone 2
increases expression
EXP
thifluzamide results in increased expression of H3C2 mRNA
CTD
PMID:33512557
NCBI chr 6:26,031,589...26,032,099
Ensembl chr 6:26,031,589...26,032,099
G
H3C3
H3 clustered histone 3
increases expression
EXP
thifluzamide results in increased expression of H3C3 mRNA
CTD
PMID:33512557
NCBI chr 6:26,045,384...26,045,869
Ensembl chr 6:26,045,384...26,045,869
G
H3C4
H3 clustered histone 4
increases expression
EXP
thifluzamide results in increased expression of H3C4 mRNA
CTD
PMID:33512557
NCBI chr 6:26,196,784...26,199,293
Ensembl chr 6:26,196,784...26,197,286
G
HERPUD1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression
EXP
thifluzamide results in increased expression of HERPUD1 mRNA
CTD
PMID:33512557
NCBI chr16:56,932,142...56,944,864
Ensembl chr16:56,932,142...56,944,864
G
HES5
hes family bHLH transcription factor 5
decreases expression
EXP
thifluzamide results in decreased expression of HES5 mRNA
CTD
PMID:33512557
NCBI chr 1:2,528,745...2,530,263
Ensembl chr 1:2,528,745...2,530,263
G
HHIP
hedgehog interacting protein
increases expression
EXP
thifluzamide results in increased expression of HHIP mRNA
CTD
PMID:33512557
NCBI chr 4:144,646,156...144,745,271
Ensembl chr 4:144,646,156...144,745,271
G
HMOX1
heme oxygenase 1
increases expression
EXP
thifluzamide results in increased expression of HMOX1 mRNA
CTD
PMID:33512557
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HNRNPM
heterogeneous nuclear ribonucleoprotein M
decreases expression
EXP
thifluzamide results in decreased expression of HNRNPM mRNA
CTD
PMID:33512557
NCBI chr19:8,444,975...8,489,114
Ensembl chr19:8,444,767...8,489,114
G
HSD17B8
hydroxysteroid 17-beta dehydrogenase 8
decreases expression
EXP
thifluzamide results in decreased expression of HSD17B8 mRNA
CTD
PMID:33512557
NCBI chr 6:33,204,655...33,206,831
Ensembl chr 6:33,204,655...33,206,831
G
HSPA8
heat shock protein family A (Hsp70) member 8
increases expression
EXP
thifluzamide results in increased expression of HSPA8 mRNA
CTD
PMID:33512557
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
G
HYOU1
hypoxia up-regulated 1
increases expression
EXP
thifluzamide results in increased expression of HYOU1 mRNA
CTD
PMID:33512557
NCBI chr11:119,044,188...119,057,205
Ensembl chr11:119,044,188...119,057,227
G
IDE
insulin degrading enzyme
increases expression
EXP
thifluzamide results in increased expression of IDE mRNA
CTD
PMID:33512557
NCBI chr10:92,451,684...92,574,093
Ensembl chr10:92,451,684...92,574,096
G
IDH3A
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha
increases expression
EXP
thifluzamide results in increased expression of IDH3A mRNA
CTD
PMID:33512557
NCBI chr15:78,149,362...78,171,945
Ensembl chr15:78,131,498...78,171,945
G
IFI44
interferon induced protein 44
decreases expression
EXP
thifluzamide results in decreased expression of IFI44 mRNA
CTD
PMID:33512557
NCBI chr 1:78,649,789...78,664,078
Ensembl chr 1:78,649,796...78,664,078
G
IFI6
interferon alpha inducible protein 6
decreases expression
EXP
thifluzamide results in decreased expression of IFI6 mRNA
CTD
PMID:33512557
NCBI chr 1:27,666,064...27,672,192
Ensembl chr 1:27,666,064...27,672,212
G
IFITM2
interferon induced transmembrane protein 2
decreases expression
EXP
thifluzamide results in decreased expression of IFITM2 mRNA
CTD
PMID:33512557
NCBI chr11:307,816...309,395
Ensembl chr11:303,655...309,397
G
IFITM3
interferon induced transmembrane protein 3
decreases expression
EXP
thifluzamide results in decreased expression of IFITM3 mRNA
CTD
PMID:33512557
NCBI chr11:319,676...320,860
Ensembl chr11:319,676...329,475
G
IFRD1
interferon related developmental regulator 1
increases expression
EXP
thifluzamide results in increased expression of IFRD1 mRNA
CTD
PMID:33512557
NCBI chr 7:112,423,174...112,477,203
Ensembl chr 7:112,422,887...112,481,017
G
IKZF1
IKAROS family zinc finger 1
decreases expression
EXP
thifluzamide results in decreased expression of IKZF1 mRNA
CTD
PMID:33512557
NCBI chr 7:50,303,455...50,405,101
Ensembl chr 7:50,304,068...50,405,101
G
INHBE
inhibin subunit beta E
increases expression
EXP
thifluzamide results in increased expression of INHBE mRNA
CTD
PMID:33512557
NCBI chr12:57,455,307...57,458,025
Ensembl chr12:57,452,323...57,459,280
G
IPO5
importin 5
increases expression
EXP
thifluzamide results in increased expression of IPO5 mRNA
CTD
PMID:33512557
NCBI chr13:97,953,675...98,024,296
Ensembl chr13:97,953,658...98,024,296
G
IRF1
interferon regulatory factor 1
increases expression
EXP
thifluzamide results in increased expression of IRF1 mRNA
CTD
PMID:33512557
NCBI chr 5:132,481,609...132,490,773
Ensembl chr 5:132,440,440...132,508,719
G
ISL1
ISL LIM homeobox 1
decreases expression
EXP
thifluzamide results in decreased expression of ISL1 mRNA
CTD
PMID:33512557
NCBI chr 5:51,383,448...51,394,730
Ensembl chr 5:51,383,448...51,394,730
G
ITPR1
inositol 1,4,5-trisphosphate receptor type 1
increases expression
EXP
thifluzamide results in increased expression of ITPR1 mRNA
CTD
PMID:33512557
NCBI chr 3:4,493,348...4,847,506
Ensembl chr 3:4,493,345...4,847,506
G
ITPR2
inositol 1,4,5-trisphosphate receptor type 2
decreases expression
EXP
thifluzamide results in decreased expression of ITPR2 mRNA
CTD
PMID:33512557
NCBI chr12:26,335,352...26,833,194
Ensembl chr12:26,335,352...26,833,194
G
JMJD6
jumonji domain containing 6, arginine demethylase and lysine hydroxylase
increases expression
EXP
thifluzamide results in increased expression of JMJD6 mRNA
CTD
PMID:33512557
NCBI chr17:76,712,836...76,726,606
Ensembl chr17:76,712,832...76,726,799
G
KARS1
lysyl-tRNA synthetase 1
decreases expression
EXP
thifluzamide results in decreased expression of KARS1 mRNA
CTD
PMID:33512557
NCBI chr16:75,627,724...75,647,665
Ensembl chr16:75,627,474...75,648,643
G
KCNQ2
potassium voltage-gated channel subfamily Q member 2
decreases expression
EXP
thifluzamide results in decreased expression of KCNQ2 mRNA
CTD
PMID:33512557
NCBI chr20:63,400,208...63,472,655
Ensembl chr20:63,400,208...63,472,677
G
KDELR2
KDEL endoplasmic reticulum protein retention receptor 2
increases expression
EXP
thifluzamide results in increased expression of KDELR2 mRNA
CTD
PMID:33512557
NCBI chr 7:6,461,089...6,484,152
Ensembl chr 7:6,445,953...6,484,190
G
KIF13A
kinesin family member 13A
decreases expression
EXP
thifluzamide results in decreased expression of KIF13A mRNA
CTD
PMID:33512557
NCBI chr 6:17,759,126...17,987,635
Ensembl chr 6:17,759,183...17,987,635
G
KIF20A
kinesin family member 20A
increases expression
EXP
thifluzamide results in increased expression of KIF20A mRNA
CTD
PMID:33512557
NCBI chr 5:138,179,112...138,187,723
Ensembl chr 5:138,178,719...138,187,723
G
KLHL24
kelch like family member 24
decreases expression
EXP
thifluzamide results in decreased expression of KLHL24 mRNA
CTD
PMID:33512557
NCBI chr 3:183,635,623...183,684,519
Ensembl chr 3:183,635,610...183,684,519
G
L1CAM
L1 cell adhesion molecule
decreases expression
EXP
thifluzamide results in decreased expression of L1CAM mRNA
CTD
PMID:33512557
NCBI chr X:153,861,514...153,886,173
Ensembl chr X:153,861,514...153,886,173
G
LAMP3
lysosomal associated membrane protein 3
increases expression
EXP
thifluzamide results in increased expression of LAMP3 mRNA
CTD
PMID:33512557
NCBI chr 3:183,122,215...183,163,813
Ensembl chr 3:183,122,215...183,163,839
G
LMOD1
leiomodin 1
decreases expression
EXP
thifluzamide results in decreased expression of LMOD1 mRNA
CTD
PMID:33512557
NCBI chr 1:201,896,456...201,946,548
Ensembl chr 1:201,896,456...201,946,548
G
LOXL1
lysyl oxidase like 1
decreases expression
EXP
thifluzamide results in decreased expression of LOXL1 mRNA
CTD
PMID:33512557
NCBI chr15:73,926,462...73,952,136
Ensembl chr15:73,925,989...73,952,137
G
LPCAT1
lysophosphatidylcholine acyltransferase 1
decreases expression
EXP
thifluzamide results in decreased expression of LPCAT1 mRNA
CTD
PMID:33512557
NCBI chr 5:1,461,427...1,523,960
Ensembl chr 5:1,456,480...1,523,962
G
MAP1LC3B
microtubule associated protein 1 light chain 3 beta
increases expression
EXP
thifluzamide results in increased expression of MAP1LC3B mRNA
CTD
PMID:33512557
NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
G
MAP2
microtubule associated protein 2
decreases expression
EXP
thifluzamide results in decreased expression of MAP2 mRNA
CTD
PMID:33512557
NCBI chr 2:209,424,047...209,734,112
Ensembl chr 2:209,424,047...209,734,147
G
MAP6
microtubule associated protein 6
decreases expression
EXP
thifluzamide results in decreased expression of MAP6 mRNA
CTD
PMID:33512557
NCBI chr11:75,586,918...75,669,038
Ensembl chr11:75,586,918...75,669,038
G
MDK
midkine
increases expression
EXP
thifluzamide results in increased expression of MDK mRNA
CTD
PMID:33512557
NCBI chr11:46,380,784...46,383,837
Ensembl chr11:46,380,756...46,383,837
G
ME1
malic enzyme 1
increases expression
EXP
thifluzamide results in increased expression of ME1 mRNA
CTD
PMID:33512557
NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
G
METRN
meteorin, glial cell differentiation regulator
decreases expression
EXP
thifluzamide results in decreased expression of METRN mRNA
CTD
PMID:33512557
NCBI chr16:715,118...719,655
Ensembl chr16:715,118...719,655
G
MOK
MOK protein kinase
increases expression
EXP
thifluzamide results in increased expression of MOK mRNA
CTD
PMID:33512557
NCBI chr14:102,214,596...102,305,164
Ensembl chr14:102,224,500...102,305,190
G
MSI2
musashi RNA binding protein 2
decreases expression
EXP
thifluzamide results in decreased expression of MSI2 mRNA
CTD
PMID:33512557
NCBI chr17:57,255,851...57,701,581
Ensembl chr17:57,255,851...57,684,689
G
MT-ND6
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6
decreases expression
EXP
thifluzamide results in decreased expression of ND6 mRNA
CTD
PMID:33512557
NCBI chr MT:14,149...14,673
Ensembl chr MT:14,149...14,673
G
MT2A
metallothionein 2A
increases expression
EXP
thifluzamide results in increased expression of MT2A mRNA
CTD
PMID:33512557
NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
G
MTHFD2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
increases expression
EXP
thifluzamide results in increased expression of MTHFD2 mRNA
CTD
PMID:33512557
NCBI chr 2:74,198,615...74,217,565
Ensembl chr 2:74,186,172...74,217,565
G
MYB
MYB proto-oncogene, transcription factor
decreases expression
EXP
thifluzamide results in decreased expression of MYB mRNA
CTD
PMID:33512557
NCBI chr 6:135,181,308...135,219,172
Ensembl chr 6:135,181,308...135,219,173
G
MYC
MYC proto-oncogene, bHLH transcription factor
increases expression
EXP
thifluzamide results in increased expression of MYC mRNA
CTD
PMID:33512557
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
G
MYL4
myosin light chain 4
decreases expression
EXP
thifluzamide results in decreased expression of MYL4 mRNA
CTD
PMID:33512557
NCBI chr17:47,189,433...47,227,650
Ensembl chr17:47,200,446...47,223,679
G
NAV1
neuron navigator 1
decreases expression
EXP
thifluzamide results in decreased expression of NAV1 mRNA
CTD
PMID:33512557
NCBI chr 1:201,539,127...201,826,969
Ensembl chr 1:201,539,127...201,826,969
G
NCAN
neurocan
decreases expression
EXP
thifluzamide results in decreased expression of NCAN mRNA
CTD
PMID:33512557
NCBI chr19:19,211,958...19,252,233
Ensembl chr19:19,211,958...19,252,233
G
NEFL
neurofilament light chain
decreases expression
EXP
thifluzamide results in decreased expression of NEFL mRNA
CTD
PMID:33512557
NCBI chr 8:24,950,955...24,956,612
Ensembl chr 8:24,950,955...24,956,721
G
NEK2
NIMA related kinase 2
increases expression
EXP
thifluzamide results in increased expression of NEK2 mRNA
CTD
PMID:33512557
NCBI chr 1:211,658,256...211,675,621
Ensembl chr 1:211,658,657...211,675,630
G
NQO1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
thifluzamide results in increased expression of NQO1 mRNA
CTD
PMID:33512557
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
NR2F1
nuclear receptor subfamily 2 group F member 1
decreases expression
EXP
thifluzamide results in decreased expression of NR2F1 mRNA
CTD
PMID:33512557
NCBI chr 5:93,583,222...93,594,611
Ensembl chr 5:93,583,222...93,594,611
G
NR3C1
nuclear receptor subfamily 3 group C member 1
increases expression
EXP
thifluzamide results in increased expression of NR3C1 mRNA
CTD
PMID:33512557
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
NR4A2
nuclear receptor subfamily 4 group A member 2
decreases expression
EXP
thifluzamide results in decreased expression of NR4A2 mRNA
CTD
PMID:33512557
NCBI chr 2:156,324,437...156,332,721
Ensembl chr 2:156,324,437...156,342,348
G
NRCAM
neuronal cell adhesion molecule
decreases expression
EXP
thifluzamide results in decreased expression of NRCAM mRNA
CTD
PMID:33512557
NCBI chr 7:108,147,649...108,456,720
Ensembl chr 7:108,147,623...108,456,717
G
NRXN1
neurexin 1
decreases expression
EXP
thifluzamide results in decreased expression of NRXN1 mRNA
CTD
PMID:33512557
NCBI chr 2:49,918,503...51,032,132
Ensembl chr 2:49,918,503...51,225,575
G
OLFML2B
olfactomedin like 2B
decreases expression
EXP
thifluzamide results in decreased expression of OLFML2B mRNA
CTD
PMID:33512557
NCBI chr 1:161,983,192...162,023,869
Ensembl chr 1:161,983,192...162,023,869
G
ORMDL3
ORMDL sphingolipid biosynthesis regulator 3
decreases expression
EXP
thifluzamide results in decreased expression of ORMDL3 mRNA
CTD
PMID:33512557
NCBI chr17:39,921,041...39,927,601
Ensembl chr17:39,921,041...39,927,601
G
P4HA2
prolyl 4-hydroxylase subunit alpha 2
increases expression
EXP
thifluzamide results in increased expression of P4HA2 mRNA
CTD
PMID:33512557
NCBI chr 5:132,190,147...132,227,853
Ensembl chr 5:132,190,147...132,295,315
G
PCDH8
protocadherin 8
increases expression
EXP
thifluzamide results in increased expression of PCDH8 mRNA
CTD
PMID:33512557
NCBI chr13:52,842,889...52,848,640
Ensembl chr13:52,842,889...52,848,641
G
PDGFB
platelet derived growth factor subunit B
decreases expression
EXP
thifluzamide results in decreased expression of PDGFB mRNA
CTD
PMID:33512557
NCBI chr22:39,223,359...39,244,982
Ensembl chr22:39,223,359...39,244,982
G
PEBP1
phosphatidylethanolamine binding protein 1
decreases expression
EXP
thifluzamide results in decreased expression of PEBP1 mRNA
CTD
PMID:33512557
NCBI chr12:118,136,124...118,145,584
Ensembl chr12:118,136,124...118,145,584
G
PEG10
paternally expressed 10
decreases expression
EXP
thifluzamide results in decreased expression of PEG10 mRNA
CTD
PMID:33512557
NCBI chr 7:94,656,325...94,669,695
Ensembl chr 7:94,656,325...94,669,695
G
PGA5
pepsinogen A5
increases expression
EXP
thifluzamide results in increased expression of PGA5 mRNA
CTD
PMID:33512557
NCBI chr11:61,241,175...61,251,444
Ensembl chr11:61,241,175...61,251,444
G
PHGDH
phosphoglycerate dehydrogenase
increases expression
EXP
thifluzamide results in increased expression of PHGDH mRNA
CTD
PMID:33512557
NCBI chr 1:119,711,934...119,744,215
Ensembl chr 1:119,648,411...119,744,218
G
PHLDA1
pleckstrin homology like domain family A member 1
decreases expression
EXP
thifluzamide results in decreased expression of PHLDA1 mRNA
CTD
PMID:33512557
NCBI chr12:76,025,447...76,031,776
Ensembl chr12:76,025,447...76,031,776
G
PINK1
PTEN induced kinase 1
decreases expression
EXP
thifluzamide results in decreased expression of PINK1 mRNA
CTD
PMID:33512557
NCBI chr 1:20,633,458...20,651,511
Ensembl chr 1:20,633,458...20,651,511
G
PLCB3
phospholipase C beta 3
decreases expression
EXP
thifluzamide results in decreased expression of PLCB3 mRNA
CTD
PMID:33512557
NCBI chr11:64,251,530...64,269,452
Ensembl chr11:64,251,530...64,269,150
G
PMAIP1
phorbol-12-myristate-13-acetate-induced protein 1
increases expression
EXP
thifluzamide results in increased expression of PMAIP1 mRNA
CTD
PMID:33512557
NCBI chr18:59,899,996...59,904,305
Ensembl chr18:59,899,996...59,904,305
G
POU4F2
POU class 4 homeobox 2
decreases expression
EXP
thifluzamide results in decreased expression of POU4F2 mRNA
CTD
PMID:33512557
NCBI chr 4:146,638,893...146,642,474
Ensembl chr 4:146,638,893...146,642,474
G
PPP1R17
protein phosphatase 1 regulatory subunit 17
decreases expression
EXP
thifluzamide results in decreased expression of PPP1R17 mRNA
CTD
PMID:33512557
NCBI chr 7:31,687,215...31,708,455
Ensembl chr 7:31,687,215...31,708,455
G
PRR11
proline rich 11
increases expression
EXP
thifluzamide results in increased expression of PRR11 mRNA
CTD
PMID:33512557
NCBI chr17:59,155,746...59,206,709
Ensembl chr17:59,155,732...59,206,709
G
PSAT1
phosphoserine aminotransferase 1
increases expression
EXP
thifluzamide results in increased expression of PSAT1 mRNA
CTD
PMID:33512557
NCBI chr 9:78,297,125...78,330,093
Ensembl chr 9:78,297,125...78,330,093
G
PTPRF
protein tyrosine phosphatase receptor type F
decreases expression
EXP
thifluzamide results in decreased expression of PTPRF mRNA
CTD
PMID:33512557
NCBI chr 1:43,522,051...43,623,666
Ensembl chr 1:43,525,187...43,623,666
G
RAB31
RAB31, member RAS oncogene family
decreases expression
EXP
thifluzamide results in decreased expression of RAB31 mRNA
CTD
PMID:33512557
NCBI chr18:9,708,301...9,862,551
Ensembl chr18:9,708,275...9,862,551
G
RBX1
ring-box 1
decreases expression
EXP
thifluzamide results in decreased expression of RBX1 mRNA
CTD
PMID:33512557
NCBI chr22:40,951,378...40,973,309
Ensembl chr22:40,951,347...40,973,309
G
RELN
reelin
decreases expression
EXP
thifluzamide results in decreased expression of RELN mRNA
CTD
PMID:33512557
NCBI chr 7:103,471,789...103,989,658
Ensembl chr 7:103,471,381...103,989,658
G
RPL28
ribosomal protein L28
increases expression
EXP
thifluzamide results in increased expression of RPL28 mRNA
CTD
PMID:33512557
NCBI chr19:55,385,932...55,403,342
Ensembl chr19:55,385,932...55,403,250
G
RPSA
ribosomal protein SA
increases expression
EXP
thifluzamide results in increased expression of RPSA mRNA
CTD
PMID:33512557
NCBI chr 3:39,406,720...39,412,542
Ensembl chr 3:39,406,716...39,426,255
G
RSL24D1
ribosomal L24 domain containing 1
increases expression
EXP
thifluzamide results in increased expression of RSL24D1 mRNA
CTD
PMID:33512557
NCBI chr15:55,180,806...55,196,941
Ensembl chr15:55,180,806...55,197,049
G
RXYLT1
ribitol xylosyltransferase 1
increases expression
EXP
thifluzamide results in increased expression of RXYLT1 mRNA
CTD
PMID:33512557
NCBI chr12:63,779,909...63,809,562
Ensembl chr12:63,779,833...63,809,792
G
SATB1
SATB homeobox 1
decreases expression
EXP
thifluzamide results in decreased expression of SATB1 mRNA
CTD
PMID:33512557
NCBI chr 3:18,345,377...18,445,592
Ensembl chr 3:18,345,377...18,445,621
G
SEL1L
SEL1L adaptor subunit of SYVN1 ubiquitin ligase
increases expression
EXP
thifluzamide results in increased expression of SEL1L mRNA
CTD
PMID:33512557
NCBI chr14:81,471,547...81,533,853
Ensembl chr14:81,471,547...81,533,853
G
SEMA6A
semaphorin 6A
decreases expression
EXP
thifluzamide results in decreased expression of SEMA6A mRNA
CTD
PMID:33512557
NCBI chr 5:116,443,555...116,574,823
Ensembl chr 5:116,443,555...116,574,823
G
SEPHS2
selenophosphate synthetase 2
increases expression
EXP
thifluzamide results in increased expression of SEPHS2 mRNA
CTD
PMID:33512557
NCBI chr16:30,443,631...30,445,874
Ensembl chr16:30,443,631...30,445,874
G
SERPINE2
serpin family E member 2
increases expression
EXP
thifluzamide results in increased expression of SERPINE2 mRNA
CTD
PMID:33512557
NCBI chr 2:223,975,045...224,039,286
Ensembl chr 2:223,975,045...224,039,318
G
SESN2
sestrin 2
increases expression
EXP
thifluzamide results in increased expression of SESN2 mRNA
CTD
PMID:33512557
NCBI chr 1:28,259,518...28,282,491
Ensembl chr 1:28,259,518...28,282,491
G
SGCB
sarcoglycan beta
decreases expression
EXP
thifluzamide results in decreased expression of SGCB mRNA
CTD
PMID:33512557
NCBI chr 4:52,020,706...52,038,299
Ensembl chr 4:52,020,706...52,038,299
G
SLC17A6
solute carrier family 17 member 6
decreases expression
EXP
thifluzamide results in decreased expression of SLC17A6 mRNA
CTD
PMID:33512557
NCBI chr11:22,338,381...22,379,503
Ensembl chr11:22,338,381...22,379,503
G
SLC1A2
solute carrier family 1 member 2
decreases expression
EXP
thifluzamide results in decreased expression of SLC1A2 mRNA
CTD
PMID:33512557
NCBI chr11:35,251,205...35,420,507
Ensembl chr11:35,251,205...35,420,063
G
SLC1A4
solute carrier family 1 member 4
increases expression
EXP
thifluzamide results in increased expression of SLC1A4 mRNA
CTD
PMID:33512557
NCBI chr 2:64,988,479...65,023,865
Ensembl chr 2:64,988,477...65,023,865
G
SLC2A6
solute carrier family 2 member 6
decreases expression
EXP
thifluzamide results in decreased expression of SLC2A6 mRNA
CTD
PMID:33512557
NCBI chr 9:133,471,094...133,479,099
Ensembl chr 9:133,471,094...133,479,127
G
SLC38A1
solute carrier family 38 member 1
increases expression
EXP
thifluzamide results in increased expression of SLC38A1 mRNA
CTD
PMID:33512557
NCBI chr12:46,183,063...46,269,043
Ensembl chr12:46,183,063...46,270,017
G
SLC3A2
solute carrier family 3 member 2
increases expression
EXP
thifluzamide results in increased expression of SLC3A2 mRNA
CTD
PMID:33512557
NCBI chr11:62,856,109...62,888,860
Ensembl chr11:62,856,004...62,888,880
G
SLC6A3
solute carrier family 6 member 3
decreases expression
EXP
thifluzamide results in decreased expression of SLC6A3 mRNA
CTD
PMID:33512557
NCBI chr 5:1,392,794...1,445,440
Ensembl chr 5:1,392,794...1,445,440
G
SLC7A5
solute carrier family 7 member 5
increases expression
EXP
thifluzamide results in increased expression of SLC7A5 mRNA
CTD
PMID:33512557
NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,023...87,869,507
G
SLIT2
slit guidance ligand 2
decreases expression
EXP
thifluzamide results in decreased expression of SLIT2 mRNA
CTD
PMID:33512557
NCBI chr 4:20,251,905...20,620,561
Ensembl chr 4:20,251,905...20,620,561
G
SNAI2
snail family transcriptional repressor 2
increases expression
EXP
thifluzamide results in increased expression of SNAI2 mRNA
CTD
PMID:33512557
NCBI chr 8:48,917,598...48,921,429
Ensembl chr 8:48,917,598...48,921,740
G
SNHG8
small nucleolar RNA host gene 8
increases expression
EXP
thifluzamide results in increased expression of SNHG8 mRNA
CTD
PMID:33512557
NCBI chr 4:118,278,762...118,279,823
Ensembl chr 4:118,278,703...118,285,316
G
SPAG5
sperm associated antigen 5
increases expression
EXP
thifluzamide results in increased expression of SPAG5 mRNA
CTD
PMID:33512557
NCBI chr17:28,577,574...28,599,025
Ensembl chr17:28,577,565...28,599,025
G
SPC25
SPC25 component of NDC80 kinetochore complex
increases expression
EXP
thifluzamide results in increased expression of SPC25 mRNA
CTD
PMID:33512557
NCBI chr 2:168,861,521...168,890,430
Ensembl chr 2:168,834,132...168,913,371
G
SPDEF
SAM pointed domain containing ETS transcription factor
decreases expression
EXP
thifluzamide results in decreased expression of SPDEF mRNA
CTD
PMID:33512557
NCBI chr 6:34,537,802...34,556,329
Ensembl chr 6:34,537,802...34,556,333
G
SPRED2
sprouty related EVH1 domain containing 2
increases expression
EXP
thifluzamide results in increased expression of SPRED2 mRNA
CTD
PMID:33512557
NCBI chr 2:65,307,175...65,432,599
Ensembl chr 2:65,310,851...65,432,637
G
SRSF10
serine and arginine rich splicing factor 10
increases expression
EXP
thifluzamide results in increased expression of SRSF10 mRNA
CTD
PMID:33512557
NCBI chr 1:23,964,347...23,980,327
Ensembl chr 1:23,964,347...23,980,927
G
SST
somatostatin
decreases expression
EXP
thifluzamide results in decreased expression of SST mRNA
CTD
PMID:33512557
NCBI chr 3:187,668,912...187,670,394
Ensembl chr 3:187,668,912...187,670,394
G
SYTL1
synaptotagmin like 1
increases expression
EXP
thifluzamide results in increased expression of SYTL1 mRNA
CTD
PMID:33512557
NCBI chr 1:27,342,022...27,353,932
Ensembl chr 1:27,342,020...27,353,937
G
TAF9
TATA-box binding protein associated factor 9
increases expression
EXP
thifluzamide results in increased expression of TAF9 mRNA
CTD
PMID:33512557
NCBI chr 5:69,364,743...69,369,824
Ensembl chr 5:69,362,026...69,370,013
G
TCF4
transcription factor 4
decreases expression
EXP
thifluzamide results in decreased expression of TCF4 mRNA
CTD
PMID:33512557
NCBI chr18:55,222,185...55,635,957
Ensembl chr18:55,222,185...55,664,787
G
TFDP1
transcription factor Dp-1
decreases expression
EXP
thifluzamide results in decreased expression of TFDP1 mRNA
CTD
PMID:33512557
NCBI chr13:113,584,688...113,641,473
Ensembl chr13:113,584,721...113,641,473
G
TGFB3
transforming growth factor beta 3
decreases expression
EXP
thifluzamide results in decreased expression of TGFB3 mRNA
CTD
PMID:33512557
NCBI chr14:75,958,097...75,983,011
Ensembl chr14:75,958,097...75,983,011
G
TMEM97
transmembrane protein 97
decreases expression
EXP
thifluzamide results in decreased expression of TMEM97 mRNA
CTD
PMID:33512557
NCBI chr17:28,319,200...28,328,685
Ensembl chr17:28,319,200...28,328,685
G
TNC
tenascin C
decreases expression
EXP
thifluzamide results in decreased expression of TNC mRNA
CTD
PMID:33512557
NCBI chr 9:115,019,575...115,118,157
Ensembl chr 9:115,019,575...115,118,207
G
TNFRSF10B
TNF receptor superfamily member 10b
increases expression
EXP
thifluzamide results in increased expression of TNFRSF10B mRNA
CTD
PMID:33512557
NCBI chr 8:23,020,133...23,069,031
Ensembl chr 8:23,020,133...23,069,031
G
TOP2A
DNA topoisomerase II alpha
increases expression
EXP
thifluzamide results in increased expression of TOP2A mRNA
CTD
PMID:33512557
NCBI chr17:40,388,525...40,417,896
Ensembl chr17:40,388,525...40,417,896
G
TPI1
triosephosphate isomerase 1
decreases expression
EXP
thifluzamide results in decreased expression of TPI1 mRNA
CTD
PMID:33512557
NCBI chr12:6,867,420...6,870,948
Ensembl chr12:6,867,119...6,870,948
G
TPX2
TPX2 microtubule nucleation factor
increases expression
EXP
thifluzamide results in increased expression of TPX2 mRNA
CTD
PMID:33512557
NCBI chr20:31,739,290...31,801,800
Ensembl chr20:31,739,271...31,801,805
G
TRIB3
tribbles pseudokinase 3
increases expression
EXP
thifluzamide results in increased expression of TRIB3 mRNA
CTD
PMID:33512557
NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559
G
TRIM13
tripartite motif containing 13
decreases expression
EXP
thifluzamide results in decreased expression of TRIM13 mRNA
CTD
PMID:33512557
NCBI chr13:49,997,042...50,018,467
Ensembl chr13:49,995,888...50,020,481
G
TRIM16L
tripartite motif containing 16 like (pseudogene)
increases expression
EXP
thifluzamide results in increased expression of TRIM16L mRNA
CTD
PMID:33512557
NCBI chr17:18,697,998...18,736,112
Ensembl chr17:18,722,237...18,735,460 Ensembl chr17:18,722,237...18,735,460
G
TSC22D3
TSC22 domain family member 3
increases expression
EXP
thifluzamide results in increased expression of TSC22D3 mRNA
CTD
PMID:33512557
NCBI chr X:107,713,221...107,775,988
Ensembl chr X:107,713,221...107,777,342
G
TTK
TTK protein kinase
increases expression
EXP
thifluzamide results in increased expression of TTK mRNA
CTD
PMID:33512557
NCBI chr 6:80,004,649...80,042,527
Ensembl chr 6:80,003,887...80,042,527
G
TUBB2A
tubulin beta 2A class IIa
decreases expression
EXP
thifluzamide results in decreased expression of TUBB2A mRNA
CTD
PMID:33512557
NCBI chr 6:3,153,666...3,157,544
Ensembl chr 6:3,153,497...3,157,544
G
TUBB2B
tubulin beta 2B class IIb
decreases expression
EXP
thifluzamide results in decreased expression of TUBB2B mRNA
CTD
PMID:33512557
NCBI chr 6:3,224,277...3,227,653
Ensembl chr 6:3,223,324...3,231,730
G
TUBB3
tubulin beta 3 class III
decreases expression
EXP
thifluzamide results in decreased expression of TUBB3 mRNA
CTD
PMID:33512557
NCBI chr16:89,921,925...89,936,097
Ensembl chr16:89,921,392...89,938,761
G
TUT7
terminal uridylyl transferase 7
decreases expression
EXP
thifluzamide results in decreased expression of TUT7 mRNA
CTD
PMID:33512557
NCBI chr 9:86,287,733...86,354,410
Ensembl chr 9:86,287,733...86,354,454
G
TXNDC5
thioredoxin domain containing 5
increases expression
EXP
thifluzamide results in increased expression of TXNDC5 mRNA
CTD
PMID:33512557
NCBI chr 6:7,881,517...7,910,788
Ensembl chr 6:7,881,517...7,910,788
G
TXNIP
thioredoxin interacting protein
decreases expression
EXP
thifluzamide results in decreased expression of TXNIP mRNA
CTD
PMID:33512557
NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579
G
TXNRD1
thioredoxin reductase 1
increases expression
EXP
thifluzamide results in increased expression of TXNRD1 mRNA
CTD
PMID:33512557
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
G
TXNRD2
thioredoxin reductase 2
increases expression
EXP
thifluzamide results in increased expression of TXNRD2 mRNA
CTD
PMID:33512557
NCBI chr22:19,875,522...19,941,818
Ensembl chr22:19,875,517...19,941,820
G
UBB
ubiquitin B
increases expression
EXP
thifluzamide results in increased expression of UBB mRNA
CTD
PMID:33512557
NCBI chr17:16,380,779...16,382,745
Ensembl chr17:16,380,798...16,382,745
G
UBE2C
ubiquitin conjugating enzyme E2 C
increases expression
EXP
thifluzamide results in increased expression of UBE2C mRNA
CTD
PMID:33512557
NCBI chr20:45,812,644...45,816,952
Ensembl chr20:45,812,576...45,816,957
G
UHRF1
ubiquitin like with PHD and ring finger domains 1
decreases expression
EXP
thifluzamide results in decreased expression of UHRF1 mRNA
CTD
PMID:33512557
NCBI chr19:4,903,080...4,962,154
Ensembl chr19:4,903,080...4,962,154
G
VEGFA
vascular endothelial growth factor A
increases expression
EXP
thifluzamide results in increased expression of VEGFA mRNA
CTD
PMID:33512557
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
VEGFD
vascular endothelial growth factor D
decreases expression
EXP
thifluzamide results in decreased expression of VEGFD mRNA
CTD
PMID:33512557
NCBI chr X:15,345,596...15,384,413
Ensembl chr X:15,345,596...15,384,413
G
VIM
vimentin
increases expression
EXP
thifluzamide results in increased expression of VIM mRNA
CTD
PMID:33512557
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
G
WARS1
tryptophanyl-tRNA synthetase 1
increases expression
EXP
thifluzamide results in increased expression of WARS1 mRNA
CTD
PMID:33512557
NCBI chr14:100,333,790...100,376,327
Ensembl chr14:100,333,790...100,376,805
G
WDTC1
WD and tetratricopeptide repeats 1
decreases expression
EXP
thifluzamide results in decreased expression of WDTC1 mRNA
CTD
PMID:33512557
NCBI chr 1:27,234,441...27,308,636
Ensembl chr 1:27,234,632...27,308,636
G
XBP1
X-box binding protein 1
increases expression
EXP
thifluzamide results in increased expression of XBP1 mRNA
CTD
PMID:33512557
NCBI chr22:28,794,560...28,800,569
Ensembl chr22:28,794,555...28,800,597
G
XIC
X chromosome inactivation center
increases expression
EXP
thifluzamide results in increased expression of XIC mRNA
CTD
PMID:33512557
G
ZEB2
zinc finger E-box binding homeobox 2
decreases expression
EXP
thifluzamide results in decreased expression of ZEB2 mRNA
CTD
PMID:33512557
NCBI chr 2:144,384,081...144,520,119
Ensembl chr 2:144,364,364...144,521,057
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all